Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma: Stemness markers and chemo-resistance
The DOI matches its Crossref record.
Abstract
BACKGROUND: Oral squamous cell carcinoma (OSCC) is the sixth most prevalent cancer worldwide. Cancer stem cells (CSC) model theoretically contribute to tumor growth, metastasis, and chemo-radioresistance. Cisplatin is a widely used chemotherapeutic agent for OSCC treatment. The aim of this study was to compare stemness genes expression in chemo-sensitive and chemo-resistant specimens and further explore the potential markers that may lead to induce chemo-resistance in OSCC. METHODS: The study method is the treatment of OC2 cells with cisplatin select cisplatin-resistant OC2 cells. Self-renewal ability was evaluated by cultivating parental and cisplatin-resistant OC2 cells within sphere-forming assay after serial passages. Differential expression profile of stemness markers between parental and cisplatin-resistant OC2 cells was elucidated. The parental and cisplatin-resistant OC2 cells were assessed for migration/invasion/clonogenicity tumorigenic properties in vitro. Expression of stemness markers in chemo-sensitive and chemo-resistant patients with OSCC was performed by immunohistochemistry staining in vivo. RESULTS: Sphere-forming/self-renewal capability was increased in cisplatin-resistant OC2 cells. Cisplatin-resistant OC2 cells highly expressed the stemness markers (Nanog, Oct4, Bmi1, CD117, CD133, and ABCG2). Furthermore, cisplatin-resistant OC2 cells increased migration/invasion/clonogenicity ability. Notably, up-regulation of Oct4 and Nanog expression was significantly observed in cisplatin-resistant patients with OSCC (**P < 0.01). CONCLUSIONS: These data indicate that cancer stem-like properties were expanded during the acquisition of cisplatin resistance in OSCC. Clinically, oral cancer stemness markers (Oct4 and Nanog) overexpression may promote the OSCC's recurrence to resist cisplatin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Targeting cancer stem cells: emerging role of Nanog transcription factor
Wu, C.-W. (., Wang, M.-L., & Chiou, S.-H. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s38114 · Cited by 169
“34 Similar phenomena were also found in oral squamous cell carcinoma, where increased Nanog and Oct4 expression was correlated with a cisplatin-resistant phenotype as well as cancer recurrence; 108 the chemoresistant cells also expressed high level of the drug-resistance-related gene ABCG2 .”
Kaufhold, S., Garbán, H., & Bonavida, B. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0359-2 · Cited by 166
“The elevated expressions of NANOG and OCT4 correlate with cisplatin resistance and recurrence in oral squamous cell carcinoma [115].”
BackgroundTargeted Cancer Stem Cell Therapeutics: An Update
Fatima, N., Umar, M., Ambreen, S., Shaququzzaman, M., Alam, M. M., & Ali, R. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266275014240110071351 · Cited by 6
Metadata
- Authors
- Tsai, L.-L., Yu, C.-C., Chang, Y.-C., Yu, C.-H., & Chou, M.-Y.
- Venue
- Journal of Oral Pathology & Medicine
- Publisher
- Wiley
- Published
- 2011-02-22
- Volume
- 40
- Issue
- 8
- Pages
- 621-628
- ISSN
- 0300-9777 (ISSN-L)
- 0904-2512
- OpenAlex
- W1734170005
- Cited by
- 191
- References
- 0
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma: Stemness markers and chemo-resistance. https://app.cochat.ai/papers/10.1111/j.1600-0714.2011.01015.x
- The paper
- Tsai, L.-L., Yu, C.-C., Chang, Y.-C., Yu, C.-H., & Chou, M.-Y. (2011). Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma: Stemness markers and chemo-resistance. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/j.1600-0714.2011.01015.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.